Zantac’s Recall Is Among the Biggest in Years

by Staff Blogger | April 27th, 2020

Heartburn, acid reflux, or gastroesophageal reflux disease (GERD)—these are all names for a common condition that almost everyone experiences from time to time. The unpleasant sensation of stomach acid entering the esophagus can range from rare occurrences to a daily or even hourly issue, depending on underlying health conditions. People who suffer from GERD take antacids, which are designed to neutralize or reduce stomach acid and prevent it from rising into the esophagus.

Unfortunately, one of the most common and widely used antacids has been recalled by its manufacturers after it was found to contain high levels of NDMA, a carcinogen. The recalls were first initiated in fall 2019, and they’re still ongoing today. Both name brand Zantac and its generic equivalents, known as ranitidine, have been recalled by their manufacturers and pulled from store shelves.

The contaminant found in Zantac is the same contaminant found in blood pressure medications that were recalled throughout 2018. People who took that medication, called losartan, as well as Zantac may be at higher risk of certain types of cancer, including bladder, stomach, intestinal, and more.

People who previously relied on Zantac and its generic to treat their GERD symptoms have had to switch to other medications, as Zantac is no longer available to purchase until its safety and quality can be assured, per the U.S. Food and Drug Administration’s guidelines. If you or someone you love took Zantac and developed cancer, you may be eligible for compensation. The Nashville drug injury lawyers at Ponce Law are here to help. Contact us today for a free consultation.